Enanta Pharmaceuticals Profit Margin

The latest profit margin for ENTA is -89.56% as of March 2026. That compares with -1.5% in the prior-year period — up 40.1% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Enanta Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, ENTA's profit margin moved from -1.5% to -89.56% — a 40.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Enanta Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, ENTA currently prints -89.56% for profit margin, while the sector average sits near 15.58%. That is roughly 674.7% below the sector mean. Large gaps often invite a closer look at Enanta Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Enanta Pharmaceuticals converts resources into returns. At -89.56%, ENTA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1.5% in the prior-year period — up 40.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ENTA's profit margin (-89.56%), review year-over-year change from -1.5%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.